- Exchange: NASDAQ GM
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Biotech
Osiris Therapeutics Inc+ Add to Watchlist
OSIR:US18.5800 USD 0.1000 0.54%
As of 10:53:54 ET on 05/29/2015.
Company Profile for Osiris Therapeutics Inc (OSIR)
Osiris Therapeutics, Inc. researches and develops therapeutic products for the regeneration of human connective tissues. The Company is focusing its initial product development efforts on the regeneration of bone marrow stroma following high-dose cancer chemotherapy, and on the regeneration of bone in long bone and spinal defects.
Osiris Therapeutics Inc
Key Executives for Osiris Therapeutics Inc (OSIR)
|Lode DebrabanderePresident/CEO||Philip R Jacoby JrCFO/Treasurer/Secretary|
|Jonathan M Hopper "Jon"Chief Medical Officer||Alla N DanilkovitchChief Scientific Officer|
|Gregory I LawVP:Finance||Frank D Czworka JrVP/General Manager:Wound Care|
|Adrian P J MolloGeneral Counsel||Amanda BadilloInvestor Relations|